Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Change in Account Payables (2018 - 2025)

Bicycle Therapeutics' Change in Account Payables history spans 8 years, with the latest figure at -$2.9 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 126.96% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached -$6.9 million, down 322.0%, while the annual FY2025 figure was -$6.9 million, 322.0% down from the prior year.
  • Change in Account Payables reached -$2.9 million in Q4 2025 per BCYC's latest filing, up from -$5.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $10.7 million in Q4 2024 to a low of -$5.9 million in Q1 2024.
  • Average Change in Account Payables over 5 years is $399150.0, with a median of -$279500.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: crashed 684.71% in 2023, then skyrocketed 1515.08% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $926000.0 in 2021, then plummeted by 355.94% to -$2.4 million in 2022, then soared by 275.82% to $4.2 million in 2023, then skyrocketed by 156.49% to $10.7 million in 2024, then crashed by 126.96% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Change in Account Payables are -$2.9 million (Q4 2025), -$5.1 million (Q3 2025), and $6.1 million (Q2 2025).